Clorox Lowers FY22 Profit Outlook; Stock Falls 8%

While reporting its results for the second quarter on Thursday, Clorox Company (CLX) lowered its profit outlook for the full year 2022. Shares of the company slipped over 8% in extended trading session.

For the full year 2022, the company now expects adjusted earnings of $4.25 to $4.50 per share and sales to decline 1 to 4 percent.

Previously, the company expected adjusted earnings of $5.40 to $5.70 per share and sales decline of 2% to 6%.

CLX closed Thursday's trading at $165.34, down $1.65 or 0.99%, on the NYSE. The stock further slipped $13.86 or 8.38% in the after-hours trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Creminelli Fine Meats is recalling around 4,207 pounds of ready-to-eat or RTE parmesan salami sticks citing misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves 2.6-oz. plastic pouches containing "CREMINELLI FINE MEATS salami minis UNCURED ITALIAN SALAMI PARMESAN" with "BES The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers. The rule titled, "Nonprescription Drug Product with an Additional Condition for Nonprescription Use," is intended to increase options for the development of safe and effective nonprescription drugs. The U.S. Food and Drug Administration announced that Australian organic infant formula and baby food producer, Bellamy's Organic, has agreed to send around 696,000 cans of general formula milk to the United States to meet the supply shortage. Under the FDA's enforcement discretion to source more infant formula to the U.S., the available Bellamy's Organic products include about 1.4 million pounds.
Follow RTT